Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.

被引：0

作者：

Von Minckwitz, Gunter

Hahnen, Eric

Fasching, Peter A.

Hauke, Jan

Schneeweiss, Andreas

Salat, Christoph

Rezai, Mandi

Blohmer, Jens U.

Zahm, Dirk Michael

Jackisch, Christian

Gerber, Bernd

Klare, Peter

Kummel, Sherko

Eidtmann, Holger

Paepke, Stefan

Nekljudova, Valentina

Le Loibl, Sibyl

Untch, Michael

Schmutzler, Rita K.

机构：

[1] Goethe Univ Frankfurt, German Breast Grp, D-60054 Frankfurt, Germany

[2] Univ Cologne, D-50931 Cologne, Germany

[3] Univ Erlangen Nurnberg, Dept Obstet & Gynecol, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany

[4] Univ Heidelberg Hosp, Heidelberg, Germany

[5] Hematol Oncol Clin, Munich, Germany

[6] Louisen Hosp, Breast Ctr Duesseldorf, Dusseldorf, Germany

[7] Brustzentrum Sankt Gertrauden Krankenhaus, Berlin, Germany

[8] Frauenklin Gera, Gera, Germany

[9] Sana Kliniken Offenbach, Offenbach, Germany

[10] Univ Rostock, D-18055 Rostock, Germany

[11] Praxisklin Krebsheilkunde, Berlin, Germany

[12] Evangel Huyssens Stiftung, Kliniken Essen Mitte, Breast Canc Ctr, Essen, Germany

[13] Univ Kiel, Kiel, Germany

[14] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynecol, D-80290 Munich, Germany

[15] German Breast Grp, Neu Isenburg, Germany

[16] Sana Klinikurn Offenbach, German Breast Grp, Neu Isenburg, Germany

[17] Helios Klinikum Berlin Buch, Dept Gynecol & Obstet, Berlin, Germany

[18] Helios Klinikum Berlin Buch, Multidisciplinary Breast Canc Ctr, Berlin, Germany

[19] Ctr Familial Breast & Ovarian Canc, Cologne, Germany

[20] Ctr Integrated Oncol, Cologne, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1005

引用

页数：1

共 50 条

[11] Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer
Barton, Mary Kay
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (03) : 155 - 156
[12] Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
Li, Fengling
Wei, Yani
Li, Li
Chen, Fei
Bao, Chunjuan
Bu, Hong
Zhang, Zhang
JOURNAL OF SURGICAL ONCOLOGY, 2024,
[13] Ki67 as a predictive biomarker for pathologic complete remission in patients with eraly triple negative breast cancer (TNBC) receiving carboplatin-containing neoadjuvant chemotherapy (NACT)
Alhaik, A.
Kolberg-Liedtke, C.
Krajewska, M.
Hoffmann, O.
Pott, B.
Petzel, A.
Bankfalvi, A.
Shaheen, M.
Stephanou, M.
Kolberg, H-C
GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E20 - E20
[14] Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
Toss, Angela
Venturelli, Marta
Civallero, Monica
Piombino, Claudia
Domati, Federica
Ficarra, Guido
Combi, Francesca
Cabitza, Eleonora
Caggia, Federica
Barbieri, Elena
Barbolini, Monica
Moscetti, Luca
Omarini, Claudia
Piacentini, Federico
Tazzioli, Giovanni
Dominici, Massimo
Cortesi, Laura
FRONTIERS IN ONCOLOGY, 2022, 12
[15] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
Krivorotko, P.
Zhiltsova, E.
Gigolaeva, L.
Emelyanov, A.
Pesotsky, R.
Ereschenko, S.
Levsghenko, V.
Nikolaev, K.
Komayachov, A.
Ivanova, O.
Tabagua, T.
Zernov, K.
Ivanov, V.
Aseeva, Z.
Bessonov, A.
Semiglazov, V.
BREAST, 2021, 56 : S52 - S52
[16] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Chen, Xi
Zhou, Zhiguo
CANCER RESEARCH, 2024, 84 (03)
[17] Pathological complete response rate (pCR) in thirty-three women with triple-negative breast cancer (TNBC) treated with a neoadjuvant carboplatin-based regimen.
Chopra, Avani
Wojtowicz, Mark
Manikowski, Jesse
Maddineni, Bhumika
Kirchner, Lester
Panikkar, Rajiv Prasanna
Vogel, Victor G.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[18] Pathological complete response rates with the addition of carboplatin to standard neoadjuvant chemotherapy in a cohort of real-world patients with triple negative breast cancer
Ramalho, S.
dA Natal, R.
Cardoso Filho, C.
Xavier, M. B.
da Silva, A. E. R.
Silva, L. R.
Vasconcelos, V.
Reinert, T.
Coelho, G. P.
Silva, G. R. dP
dos Santos, C. C.
CANCER RESEARCH, 2019, 79 (04)
[19] Role of different germline BRCA mutations in response to platinum-based chemotherapy in patients (pts) with triple-negative breast cancer (TNBC).
Frolova, Mona
Ignatova, Ekaterina
Stenina, Marina B.
Petrovsky, Alexander
Tjulandin, Sergei
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[20] Efficacy of platinum-based neoadjuvant chemotherapy in early triple-negative breast cancer according to germline BRCA mutation
Bae, S. J.
Jang, J. S.
Kook, Y.
Baek, S. H.
Kim, J. H.
Kim, M. J.
Lee, S. E.
Moon, S.
Kim, J. H.
Ahn, S. G.
Jeong, J.
BREAST, 2023, 68 : S59 - S60

← 1 2 3 4 5 →